急诊行CTPA患者中肺栓塞与COVID-19的关联:PEPCOV国际回顾性研究
该国际回顾性研究纳入6个国家26个急诊科在疫情高峰期2个月内因疑诊肺栓塞而行CTPA的患者,共分析3253例,其中974例(30%)诊断为COVID-19。CTPA诊断肺栓塞500例(15%),COVID-19组与非COVID-19组肺栓塞发生率均为15%。多变量二元logistic回归显示COVID-19与肺栓塞风险无关联(调整OR=0.98,95%CI 0.76–1.26),限定疫情期患者的敏感性分析结果一致。作者结论认为,在因疑诊肺栓塞行CTPA的急诊患者中,COVID-19并不增加肺栓塞诊断概率,但结果可能不适用于一般疑似COVID-19患者。
要点
- 在因疑诊肺栓塞行CTPA的急诊患者中,COVID-19组与非COVID-19组肺栓塞发生率均为15%。
- 多变量logistic回归显示COVID-19与肺栓塞诊断无关联,调整OR=0.98(95%CI 0.76–1.26)。
- 限定于疫情高峰期纳入患者的敏感性分析中,COVID-19与肺栓塞仍无关联。
- 共分析3253例,其中974例(30%)诊断为COVID-19,500例(15%)CTPA诊断肺栓塞。
- 作者结论:结果可能不适用于一般疑似COVID-19患者。
适用人群与场景
- 6个国家26个急诊科在覆盖疫情高峰期的2个月期间,因疑诊肺栓塞而行CTPA的急诊患者。
- 共3358例纳入,其中105例因COVID-19状态未知被排除,3253例进入分析;平均(±SD)年龄61(±19)岁,52%为女性。
诊断标准与关键阈值
- COVID-19在急诊通过CT或逆转录聚合酶链反应诊断。
- 主要终点为CTPA上诊断肺栓塞。
研究设计与关键结果
- 研究类型为国际回顾性研究,涉及6个国家26个急诊科,分析3253例因疑诊肺栓塞行CTPA的急诊患者。
- 974例(30%)诊断为COVID-19;500例(15%)经CTPA诊断肺栓塞。
- COVID-19组与非COVID-19组肺栓塞风险相似,两组均为15%。
- 多变量二元logistic回归中,COVID-19与肺栓塞风险无关联,调整OR=0.98(95%CI 0.76–1.26)。
- 限定于疫情高峰期纳入患者的敏感性分析中,COVID-19与肺栓塞仍无关联。
证据类型、等级与局限
- 证据类型:国际回顾性研究。
- 局限:作者指出结果可能不适用于一般疑似COVID-19患者。
对床旁实践的改变
- 作者结论:在因疑诊肺栓塞行CTPA的急诊患者中,COVID-19与肺栓塞诊断概率升高无关。
- 作者结论:该结果在限定于疫情高峰期时仍然成立。
- 作者指出:这些结果可能不适用于一般疑似COVID-19患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There have been reports of procoagulant activity in patients with COVID-19. Whether there is an association between pulmonary embolism (PE) and COVID-19 in the emergency department (ED) is unknown. The aim of this study was to assess whether COVID-19 is associated with PE in ED patients who underwent a computed tomographic pulmonary angiogram (CTPA).
METHODS: A retrospective study in 26 EDs from six countries. ED patients in whom a CTPA was performed for suspected PE during a 2-month period covering the pandemic peak. The primary endpoint was the occurrence of a PE on CTPA. COVID-19 was diagnosed in the ED either on CT or reverse transcriptase-polymerase chain reaction. A multivariable binary logistic regression was built to adjust with other variables known to be associated with PE. A sensitivity analysis was performed in patients included during the pandemic period.
RESULTS: A total of 3,358 patients were included, of whom 105 were excluded because COVID-19 status was unknown, leaving 3,253 for analysis. Among them, 974 (30%) were diagnosed with COVID-19. Mean (±SD) age was 61 (±19) years and 52% were women. A PE was diagnosed on CTPA in 500 patients (15%). The risk of PE was similar between COVID-19 patients and others (15% in both groups). In the multivariable binary logistic regression model, COVID-19 was not associated with higher risk of PE (adjusted odds ratio = 0.98, 95% confidence interval = 0.76 to 1.26). There was no association when limited to patients in the pandemic period.
CONCLUSION: In ED patients who underwent CTPA for suspected PE, COVID-19 was not associated with an increased probability of PE diagnosis. These results were also valid when limited to the pandemic period. However, these results may not apply to patients with suspected COVID-19 in general.
参考来源
- Freund Y, Drogrey M, Miró Ò, et al. Association Between Pulmonary Embolism and COVID-19 in Emergency Department Patients Undergoing Computed Tomography Pulmonary Angiogram: The PEPCOV International Retrospective Study. Acad Emerg Med. 2020. PMID: 32734624. doi:10.1111/acem.14096
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。